NIH, NINR, and AHRQ Funding Opportunity Announcements
Dates and Deadlines | Title | Summary Information |
---|---|---|
RFA Release: anticipated June 13, 2022 Informational Webinar: June 29, 2022 @ 2pm ET. Register HERE Applications Due: September 1, 2022 @ 5pm ET. |
NIA: Notice of Intent to Publish FOA for IMPACT Career Development Awards |
The NIA IMPACT Collaboratory plans to publish a RFA for CDA Program. The IMPACT Collaboratory plans to fund up to 2 CDAs in this cycle. For more information, click HERE. RFA is expected to be published on June 13, 2022 on impactcollaboratory.org Questions related to this funding opportunity? Contact IMPACTcollaboratory@hsl.harvard.edu |
Notice Number: NOT-CA-22-077 Release Date: April 08, 2022 Estimated Publication Date of Funding Opportunity Announcement: May 27, 2022 First Estimated Application Due Date: September 01, 2022 Earliest Estimated Award Date: July 01, 2023 Earliest Estimated Start Date: July 30, 2023 |
The NCI intends to publish a new funding opportunity regarding the needs of individuals living with advanced cancer. |
|
Open Date: Sept. 10, 2021 Expires: Feb. 14, 2024 |
This Funding Opportunity Announcement (FOA) will support pragmatic trials within Stage IV of the NIH Stage Model to improve dementia care across multiple dementia care settings that will: (1) be designed to address practical comparative questions faced by Alzheimer’s disease (AD) and AD-related dementia (ADRD) patients, clinicians, and caregivers (both paid and unpaid); (2) include broad and diverse populations; and (3) be conducted in real-world settings with adequate sample size. These trials are intended to produce results that can be directly adopted by healthcare providers, patients, or caregivers for rapid dissemination and implementation. Successful applications will: (1) improve quality of care of persons with dementia; (2) improve quality of life for persons with dementia and their informal caregivers; (3) deliver more patient-focused, cost-effective care across multiple settings; and/or (4) reduce disparities in dementia care. This FOA will support Stage I or Stage III pilot research to test the feasibility of implementing and integrating interventions (R61 phase) that, if successful, can transition to an R33 phase (Stage IV) for implementation of large pragmatic trials. The transition from the R61 to the R33 phase of the award will be administratively reviewed and determined by successful completion of the go/no-go criteria that are specified for the R61 phase. |
|
Open Date: Sept. 10, 2021 Expires: Feb. 14, 2024 |
PAR-21-307: Dementia Care and Caregiver Support Intervention Research (R01 Clinical Trial Required) |
This Funding Opportunity Announcement (FOA) solicits mechanism-focused dementia care and caregiver support intervention development research at Stages I through V of the NIH Stage Model to address the care needs and promote the health, function, and well-being of persons with Alzheimer’s disease (AD) and Alzheimer’s disease-related dementias (ADRD) and of those providing their care. The NIH Stage Model offers a framework to: (1) support development of efficacious interventions that are defined by their principles; and (2) ensure that these efficacious interventions can be administered in the community or in health systems with fidelity to the intervention’s principles. This includes the development, testing, and validation of scalable training materials and procedures so that these interventions can be delivered with fidelity in community settings or health systems. Settings can include the home, community, or formal care settings, such as nursing homes, assisted living facilities, nursing and rehabilitation centers, hospitals, adult day care, and specialized hospice settings. The overarching purpose of this FOA is to help to lay the groundwork for real-world implementation of AD/ADRD care and caregiving interventions. The principle-based interventions under development may target behavioral, psychological, interpersonal, social, or institutional processes and may be designed for use at the individual, family, dyad, group, community, or health-systems level. Applications may propose mechanism-focused intervention research for individuals living with dementia or for individuals or systems providing care for people at any stage of AD/ADRD. Applications proposing the development of interventions that address the principles underlying the care needs and challenges for individuals from diverse racial, ethnic, and socioeconomic backgrounds are strongly encouraged. Applications that involve interdisciplinary expertise and translational expertise (e.g., basic behavioral, social, psychological, or neurobiological science expertise relevant to hypothesized intervention mechanisms; expertise in the AD/ADRD service delivery system; and clinical psychological science expertise in areas outside of aging or AD/ADRD, but potentially relevant to AD/ADRD caregiver research, etc.) are also strongly encouraged. Applications may propose to create, modify, and test AD/ADRD care and caregiver support interventions based upon hypothesized mechanisms of action and are encouraged to incorporate a test of essential components or mechanisms of change using an appropriate methodological approach. |
Other Funding and Training Opportunities
Dates and Deadlines | Title | Summary Information |
---|---|---|
Rolling deadline
|
Palliative Care and Aging Research Training (T32) Opportunity |
Funded by a Ruth Kirschstein National Research Service Award NRSA T32 from the National Institute on Aging (NIA), this Program builds on the significant Palliative Care expertise and research opportunities within the University of Colorado. Participants become members of the community of scholars at the University of Colorado and are provided with the full array of resources available within the Department of Medicine and the Colorado Clinical & Translational Sciences Institute (CCTSI). More information about T32 opportunities at Colorado University Palliative Care Post-Doctoral |
Application Due Date: February 1st of desired start year Candidates will be selected on a rolling basis each year until each of the two new slots per year are filled. |
Weill Cornell Medicine Post-Doctoral Training Program in Behavioral Geriatrics (T32) |
This 2-year Postdoctoral Training Program in Behavioral Geriatrics develops independent investigators capable of conducting patient-oriented research to improve the quality of life and quality of care of older adults. The Program is co-led by Cary Reid, MD, PhD, Director of the Translational Research Institute on Pain in Later Life and Holly G. Prigerson, PhD, Director of the Center for Research on End-of-Life Care both based in the Department of Medicine, Division of Geriatrics and Palliative Medicine at Weill Cornell Medicine. Applications are accepted from both MD and PhD postdoctoral trainees (2/year) seeking careers at the intersection of biomedical and innovative social/behavioral approaches to improve care and care outcomes in older adults. Please see the links below for more information:
|
Applications are accepted on a rolling basis for a variety of potential start dates |
Cambia Palliative Care Center of Excellence Palliative Care Research Fellowship Program |
Fellowships will be 1-3 years in duration. Trainees must have an interest in palliative care research related to heart, lung or blood disease. For more details and information about the Palliative Care Research Fellowship, please visit http://www.uwpalliativecarecenter.com |